Impulse control disorders and dopamine agonists
Introduction Impulse control disorders (ICDs) are an adverse effect of dopamine agonists (DAAs) that affects the quality of life and can lead to legal, criminal and familiar problems. Objectives Presenting a review of the mechanisms, prevalence and factors associated with the development of an I...
Main Authors: | D. Martins, R. Faria, M. Pinho, S. Rodrigues |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821012682/type/journal_article |
Similar Items
-
Progress in the treatment with dopamine receptor agonist-induced impulse control disorders
by: ZHANG Rui, WU Xue-yan
Published: (2022-09-01) -
Impulse Control Disorders in the Polish Population of Patients with Parkinson’s Disease
by: Mateusz Toś, et al.
Published: (2023-08-01) -
Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
by: José Miguel Hinojosa-Amaya, et al.
Published: (2020-10-01) -
Impulse control and related behavioral disorders (ICRD) in Idiopathic Parkinson’s Disease treated with different dopamine agonists in Hong Kong: Is any dopamine agonist better?
by: Hiu Fung Wu, et al.
Published: (2024-01-01) -
Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome
by: Reiff Julia, et al.
Published: (2011-09-01)